Editorial: Co-morbidity of COVID 19 and fungal infections.
作者信息
Pandey Ramendra Pati, Dhiman Ruby, Mishra Vivek, Raj V Samuel, Chang Chung-Ming
机构信息
School of Health Sciences and Technology (SoHST), UPES, Dehradun, Uttarakhand, India.
Amity Institute of Click-Chemistry Research and Studies (AICCRS), Amity University Uttar Pradesh, Noida, India.
出版信息
Front Fungal Biol. 2024 Sep 16;5:1462172. doi: 10.3389/ffunb.2024.1462172. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Co-morbidity of COVID 19 and fungal infections.社论：新型冠状病毒肺炎与真菌感染的合并症
Front Fungal Biol. 2024 Sep 16;5:1462172. doi: 10.3389/ffunb.2024.1462172. eCollection 2024.
2
When to Initiate Antifungal Treatment in COVID-19 Patients with Secondary Fungal Co-infection.新型冠状病毒肺炎继发真菌合并感染患者何时开始抗真菌治疗
Curr Clin Microbiol Rep. 2022;9(4):60-68. doi: 10.1007/s40588-022-00184-0. Epub 2022 Nov 3.
3
Fungal Infections Identified with Multiplex PCR in Severe COVID-19 Patients during Six Pandemic Waves.在六波大流行期间，通过多重 PCR 鉴定出严重 COVID-19 患者中的真菌感染。
Medicina (Kaunas). 2023 Jul 5;59(7):1253. doi: 10.3390/medicina59071253.
4
Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants.危重症COVID-19患者合并真菌感染的危险因素，重点关注免疫抑制剂。
J Fungi (Basel). 2021 Jul 9;7(7):545. doi: 10.3390/jof7070545.
5
Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review.新冠病毒合并感染患者的真菌感染：病例报告/病例系列概述与系统评价
Front Microbiol. 2022 Jul 6;13:888452. doi: 10.3389/fmicb.2022.888452. eCollection 2022.
6
Diagnosis and Outcomes of Fungal Co-Infections in COVID-19 Infections: A Retrospective Study.新型冠状病毒肺炎合并真菌感染的诊断与结局：一项回顾性研究
Microorganisms. 2023 Sep 15;11(9):2326. doi: 10.3390/microorganisms11092326.
7
COVID-19 and Plethora of Fungal Infections.新型冠状病毒肺炎与多种真菌感染
Curr Fungal Infect Rep. 2022;16(2):47-54. doi: 10.1007/s12281-022-00432-2. Epub 2022 Apr 9.
8
Antifungal therapy in the management of fungal secondary infections in COVID-19 patients: A systematic review and meta-analysis.COVID-19 患者真菌感染的抗真菌治疗：系统评价和荟萃分析。
PLoS One. 2022 Jul 28;17(7):e0271795. doi: 10.1371/journal.pone.0271795. eCollection 2022.
9
Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units.在重症监护病房住院的新冠肺炎患者呼吸道的真菌和细菌合并感染
Gene Rep. 2022 Jun;27:101588. doi: 10.1016/j.genrep.2022.101588. Epub 2022 Mar 8.
10
Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU).真菌感染与入住重症监护病房（ICU）的COVID-19患者死亡率增加无关。
Crit Care Res Pract. 2023 Sep 9;2023:4037915. doi: 10.1155/2023/4037915. eCollection 2023.
本文引用的文献
1
Autophagy as a Therapeutic Target for Chronic Kidney Disease and the Roles of TGF-β1 in Autophagy and Kidney Fibrosis.自噬作为慢性肾脏病的治疗靶点及 TGF-β1 在自噬和肾脏纤维化中的作用。
Cells. 2023 Jan 26;12(3):412. doi: 10.3390/cells12030412.
2
Silver Nanoparticles Phytofabricated through : Anticancer, Apoptotic, and Wound-Healing Properties.通过植物合成的银纳米颗粒：抗癌、凋亡和伤口愈合特性
Antibiotics (Basel). 2023 Jan 9;12(1):121. doi: 10.3390/antibiotics12010121.
3
Revisiting the Vital Drivers and Mechanisms of β-Glucan Masking in Human Fungal Pathogen, .重新审视人类真菌病原体中β-葡聚糖掩盖的关键驱动因素和机制
Pathogens. 2021 Jul 27;10(8):942. doi: 10.3390/pathogens10080942.
4
Gefitinib Results in Robust Host-Directed Immunity Against Infection Through Proteo-Metabolomic Reprogramming.吉非替尼通过蛋白质组代谢组重编程导致针对 感染的强大的宿主定向免疫。
Front Immunol. 2021 Mar 31;12:648710. doi: 10.3389/fimmu.2021.648710. eCollection 2021.
5
New Approaches for the Treatment of Chagas Disease.治疗恰加斯病的新方法。
Curr Drug Targets. 2021;22(7):835-841. doi: 10.2174/1389450121999201124122643.
6
Development of potential proteasome inhibitors against .开发针对. 的潜在蛋白酶体抑制剂。
J Biomol Struct Dyn. 2022 Mar;40(5):2189-2203. doi: 10.1080/07391102.2020.1835722. Epub 2020 Oct 19.
Zotero 插件